Synektik SA (SNT.WA) stock: key figures, P/E, revenue and dividend

Health Care · Poland · ISIN PLSNKTK00019

Price
332.80 PLN
Market cap
2.84 bn PLN
P/E (2025)
27.78
P/S (2025)
4.17
Dividend yield
3.23 %
Net margin
14.98 %
Return on equity (ROE)
45.78 %
Return on assets (ROA)
20.96 %

Synektik SA financials

Fiscal year20242025
Revenue624.00 m PLN681.00 m PLN
Gross profit189.00 m PLN242.00 m PLN
EBIT107.00 m PLN157.00 m PLN
Net income82.00 m PLN102.00 m PLN
Diluted EPS – continuing operations9.68 PLN11.98 PLN

Full history since 2009, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Synektik SA

Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as research, produces, and sells radiopharmaceutical products used in diagnostics for oncology. In addition, it offers maintenance services for medical equipment, as well as acceptance and specialist tests. The company was founded in 2001 and is based in Warsaw, Poland.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.